0
Is olaparib the only PARP inhibitor that has been approved?
- 1 people answered
0 Vote
1 Contributor
1962 Views 
0 Saved
0 Vote 1 Contributor1962 Views 0 SavedYou might also be interested in
Early signs of cancer could be unexplained weight loss, a lump or swelling, unusual bleeding, persistent fatigue or changes in skin. Some people also notice long-lasting coughs or changes in bowel habits. If you experience any of these symptoms, it is recommended to consult the best oncologist avail....
This is one of those 'beliefs' that pop up from time to time. There is no proven link between deodorant use and breast cancer. Any studies completed to date have not been adequate to show proof. There are lots of things that are believed to cause cancer and very few of them have been proven because ....
Two tests may be better than one. That’s the conclusion of researchers in a new study that looked at the reliability of both ultrasounds and mammograms. Where mammography is available, ultrasound should be seen as a supplemental test for women with dense breasts who do not meet high-risk criteria....
Rahul Sharma
Yes, PARP inhibitors are relatively newer class of drugs and scientists have just begun to explore their functionality and usage in Cancer treatment. LYNPARZA is the first and only PARP inhibitor approved in 2 distinct settings: For the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, who are in complete or partial response to platinum-based chemotherapy. For the treatment of adult patients with suspected deleterious germline BRCA-mutated advanced ovarian cancer which has been treated with 3 or more prior lines of chemotherapy. Patients should be selected for therapy based on an FDA-approved companion diagnostic for LYNPARZA. Poly (ADP-ribose) Polymerase, or PARP, enzymes mediate DNA repair by transferring ADP-ribose units to preexisting ADP-ribose chains on proteins and to proteins. This ADP–ribosylation process recruits DNA repair enzymes, thereby maintaining genomic integrity. Inhibiting this process can lead to the accumulation of DNA damage and, ultimately, cell death.